Incyte Corp at Goldman Sachs CEOs Unscripted Conference Transcript

Jan 05, 2023 / 02:45PM GMT
Salveen Jaswal Richter - Goldman Sachs Group, Inc., Research Division - VP

Great. Good morning, everyone. Thanks so much for joining us. We're really pleased to have Herve Hoppenot, Chairman, President and CEO of Incyte with us. And in the audience, we do have Christiana Stamoulis, CFO, as well. So thank you both.

Questions and Answers:

Salveen Jaswal Richter - Goldman Sachs Group, Inc., Research Division - VP

Herve, just to start here, a high-level outlook. Product diversification for Incyte has been a focus. And as you stand today with Jakafi, Pemazyre, Monjuvi, Opzelura, and the current pipeline, what is your outlook for the business at this point and growth in the medium and long term?

Herve Hoppenot - Incyte Corporation - Chairman, President & CEO

Salveen, thank you for inviting me. It's a pleasure to start the year here and speak about Incyte. So Incyte is obviously about innovation and growth. I mean that's really what the agenda is for us and has been for the past 5 years. And if you look back at
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot